Now Available: Vetoryl Flavoured Tablets For Dogs
02 June 2025
Vetoryl Flavoured Tablets for Dogs are now available for the treatment of Canine Cushing’s syndrome.
Our new Vetoryl Flavoured Tablets for Dogs are hydrolysed chicken flavoured tablets featuring SmartTabTM technology which allows the tablets to be easily divided into halves or quarters, ensuring flexible dosing options. They are available as 20mg, 30mg and 60mg tablets, available alongside the current Vetoryl 5mg, 10mg, 30mg, 60mg and 120mg hard capsules and come in packs of 30 tablets.
Vetoryl contains Trilostane as its active ingredient and is licensed for the treatment of pituitary-dependent and adrenal-dependent hyperadrenocorticism (Cushing’s Syndrome) in dogs. It has been on the market for 20 years with over 300 million capsules sold since its launch and is supported by a combination of Dechra’s extensive technical endocrinology experience and its comprehensive support initiatives.